Huagai Capital

Synaire engaged in the research and development, production and other related businesses of home ventilators, oxygen concentrators, and non-invasive ventilators.

Shanghai Bioshine Biotechnology Co. is a bitotech company offering biopharmaceutical, medical research, and in vitro diagnostic solutions.

ViGeneron GmbH specializes in developing gene therapies aimed at treating ophthalmic diseases, particularly those with significant unmet medical needs. Founded in 2017 and based in Starnberg, Germany, the company utilizes two proprietary adeno-associated virus (AAV) technology platforms. The first, vgAAV, enhances transduction efficiency and allows for less invasive intravitreal treatment administration. The second platform, REVeRT, addresses diseases linked to mutations in large genes. ViGeneron's innovative approach aims to generate full-length proteins with high precision, facilitating the advancement of novel therapies for retinal disorders. The company also seeks partnerships with leading biopharmaceutical firms to expand its impact in other disease areas.

Index Technology is a company that specializes in applying artificial intelligence technology to electronic design and production. Index Technology uses generative AI technology to optimize the traditional R&D process for electrical devices, and it offers automated generation services ranging from product requirements to PCBA manufacturing designs and supporting embedded programs.

Amazinc is a zinc battery R&D and production company that specializes in zinc battery development and manufacture.Amazinc offering a systematic design of leading zinc-based battery solutions, including energy storage mechanisms, battery materials, and structural design.

Baijun Biotechnology is a major player in the field of biopharmaceutical R&D services due to its one-stop biotechnology R&D service platform, strong R&D skills, and extensive industry experience.

Ai Sensing Technology is a national high-tech enterprise that focus on the research, development and production of bionic olfactory chips.

Micro Interventional is a company that develops active interventional innovative medical devices. It emphasizes the development of novel medical devices with a product strategy centered on the precise interventional treatment of coronary heart disease and peripheral arterial disease.

Cybernetics is a producer of digital energy solutions and products based on electrical measuring technology.

Utarn Technology is a technology company that specializes in pulsed neural network technology, which is a form of third-generation artificial intelligence. The company focuses on the commercial application of brain-like artificial intelligence, utilizing multi-layer training algorithms to create innovative solutions. One of its key products is the "Zhi Zunbao," an intelligent robot designed to assist individuals in decision-making by mimicking biological brain functions, thereby enhancing efficiency and reducing costs. Utarn Technology also explores advancements in the fields of big entertainment and autonomous driving through its Game Mate and Car Mate series robots, which aim to further integrate intelligent systems into everyday life.

Bluesail Surgical is a surgical device company that specializes in the development of innovative surgical instruments for cardiovascular and cerebrovascular treatments.

Bowang Pharmaceutical is an RNAi drug research and development platform focused on siRNA drug development.

Leo Summit is positioned as a provider of life science laboratory automation solutions. It provides reliable and flexible solutions for the biomedical industry, driven by the demand for automated intelligent technology in clinical medicine and drug R&D industries, and relies on artificial intelligence and motion control technology. Provide systematic intelligent products and solutions for R&D firms, AI pharmaceuticals, and CRO firms in the fields of new medications, synthetic biology, and single-cell sequencing.

Leaf Biotech is engaged in the research, development, production, and sales of green chemical materials and intermediates. The company specializes in biomass resources and focuses on bio-based polyester materials, specifically Polyethylene Furanoate (PEF) and its key intermediates, such as furandicarboxylic acid (FDCA). In addition to its work in sustainable materials, Leaf Biotech is involved in the creation of green pharmaceuticals and healthcare intermediates, contributing to the development of environmentally friendly solutions. Through these efforts, the company aims to promote sustainability while addressing the needs of various industries.

Dingzhi Biotech specialized in immunology and animal vaccine development. It focuses on innovative and large varieties in the research of covers poultry, livestock, and pets.

Chromai specializes in high-performance intelligent liquid chromatography and medical diagnostic solutions, focusing on simplifying the diagnostic and testing processes. The company employs advanced technologies such as artificial intelligence, Big Data, and the Internet of Things, integrating these with leading analysis and detection methods. Chromai is dedicated to enhancing the fields of health in vitro diagnostics, environmental protection, and scientific instruments. Committed to independent innovation, the company aims to contribute to the revitalization of national industry while providing efficient diagnostic and testing analysis for medical users.

Sangon Biotech Co. is a biotechnology company founded in 2003 as a Sino-foreign joint venture, specializing in the research and development of chemical synthesis of DNA. Over the years, Sangon has established itself as a key player in the global biotechnology market, known for its expertise in DNA synthesis, sequencing, and gene synthesis. The company has invested significantly in its infrastructure, including a manufacturing and industrial base in Songjiang Industrial Park. Sangon offers a wide range of products and services, including molecular biology kits, biochemicals, synthetic genes, oligos, peptide synthesis, enzymes, and laboratory consumables. By providing affordable life science research tools and services, Sangon supports researchers in advancing basic research and product development in the life sciences field.

Jinfang Pharmaceutical is focused on R&D and drug development from small molecule drug pipelines to diversified cutting-edge therapies.

LIBAOTE is a manufacturing company specializing in the supply of fresh and frozen meat to restaurants and retail outlets. It operates a mobile application that facilitates a streamlined ordering process for catering businesses, enabling them to access high-quality protein products easily. The company manages its own supply chain, which includes overseas supplier resources, independent storage, procurement operations, and quality inspection teams. This comprehensive approach ensures that LIBAOTE can deliver reliable and high-quality meat supplies to its clients efficiently.

Chengdu Qitan Technology Co., Ltd. specializes in the development and manufacture of advanced gene sequencing instruments utilizing nanopore technology. Founded in 2016 and based in Chengdu, China, the company offers a fourth generation gene sequencer that enables single-molecule sequencing with long read lengths and real-time output. This innovative technology is designed to serve various sectors, including biopharmaceuticals, healthcare, and agriculture, facilitating applications such as immunophenotyping, pathogen detection, analysis of intestinal flora, and tumor genome detection. Qitan Tech's solutions are notable for their cost-effectiveness and simplicity, as they do not require complicated library preparation, thus enhancing the accessibility of gene sequencing for cutting-edge biological research and clinical diagnostics.

Leo Summit is positioned as a provider of life science laboratory automation solutions. It provides reliable and flexible solutions for the biomedical industry, driven by the demand for automated intelligent technology in clinical medicine and drug R&D industries, and relies on artificial intelligence and motion control technology. Provide systematic intelligent products and solutions for R&D firms, AI pharmaceuticals, and CRO firms in the fields of new medications, synthetic biology, and single-cell sequencing.

Carmine Therapeutics is focused on developing a novel gene therapy platform that harnesses extracellular vesicles produced from red blood cells. This innovative approach aims to address limitations associated with traditional viral-based gene therapies, such as immunogenicity, small transgene capacity, and manufacturing challenges. The company's technology is designed to generate a diverse pipeline of gene therapies targeting hematology, oncology, and immunology, offering new treatment options for patients facing these medical conditions. By leveraging this proprietary platform, Carmine Therapeutics seeks to advance the development of a new class of medicines.

Ubrigene is driven by the advancement of gene and cell therapy technologies through research and development represented by AAV vectors. It can provide a comprehensive solution for gene therapy industrialization.

Deepway is a manufacturer of smart vehicles focused on the truck freight market, offering advanced intelligent driving solutions. The company designs heavy-duty trucks characterized by low wind resistance and high-level intelligent driving capabilities. Its vehicles feature a distributed drive system with a modular design that operates on a unified hydrogen and electricity platform. This innovative approach allows the logistics industry to leverage smart freight systems, enhancing efficiency and sustainability in transportation.

MobiDrop specializes in developing microfluidic technologies aimed at enhancing life sciences and precision medicine. The company creates advanced instruments, comprehensive assays, and user-friendly software designed for digital droplet PCR (ddPCR) and single-cell multi-omic platforms. MobiDrop is dedicated to innovating molecular diagnostics and life science research by improving the quality of diagnosis and testing. Its product portfolio includes integrated machine platforms, microfluidic detection chips, and supporting reagents, which find applications in molecular diagnostics, cancer screening, and drug research and development. Through these offerings, MobiDrop contributes significantly to the advancement of life science research and in vitro diagnostics.

Huojianpai is a commercial aerospace company providing earth-moon space economy and future-oriented deep space exploration.

Kingstar is a fintech service provider that specializes in delivering comprehensive solutions for large financial institutions. The company focuses on the digital transformation of the capital markets, offering a range of services including trading management systems, risk management solutions, and educational software. Kingstar's expertise encompasses distributed architecture transaction support and operational systems specifically tailored for the securities industry. Additionally, the firm provides risk and internal control management systems that address the needs of the financial securities sector throughout various stages of operation. By concentrating on areas such as capital markets and enterprise risk management, Kingstar aims to enhance efficiency for organizations, private sectors, and government agencies.

Shanghai Perfect Match Flexible Supply Chain Service is an operator for catering and retail fresh food supply chains. Their services include a central kitchen industrial park, fresh delivery, low-temperature storage, intercity transport, and cold chain transportation.

Reistone Biopharma is a clinical stage biopharmaceutical company dedicated to the rapid development of innovative medicines aimed at addressing autoimmune and inflammatory diseases with significant unmet medical needs. The company concentrates on creating treatments for inflammatory bowel diseases, including ulcerative colitis and Crohn's disease, as well as dermatological conditions such as atopic dermatitis. Through global collaborations in research and development, Reistone Biopharma seeks to advance its pipeline of novel therapies to improve patient outcomes in these challenging medical areas.

Clounix is a software startup specializing in high-performance network chips and solutions, particularly focusing on application-specific integrated circuits (ASICs) designed for cloud networking. The company is dedicated to enhancing cloud networking technology through the development of ASICs that facilitate high-speed packet switching. Clounix supports super-internet companies, medium and large enterprises, and network operators in building next-generation networks and data centers. By creating advanced hardware and tailored software that align with cloud-native ecosystems, Clounix plays a crucial role in the evolution of modern networking infrastructure, catering to the needs of global Internet manufacturers and businesses seeking to improve their network capabilities.

Singlomics is a biotechnology company that specializes in single-cell sequencing technology to facilitate antibody drug development aimed at treating infectious diseases and cancers. The company has made significant advancements in antibody discovery, having developed neutralizing antibodies such as DXP593 and DXP604, which offer potential solutions in the fight against COVID-19. By leveraging its innovative technology, Singlomics focuses on creating targeted therapies that address critical health challenges.

Chuanxin Biotech is an RNA drug research and development service provider.

GenFleet Therapeutics, based in Shanghai, China, is a biotechnology company focused on the research and development of therapeutic molecules aimed at cancer treatment. Founded in 2017, the company specializes in creating innovative molecular pharmaceuticals and antibody drugs that target various cancer systems. GenFleet's work involves developing signal transduction regulators, tumor microenvironment modulators, and transcription factors, among other therapeutic agents. The company's mission is to provide effective medical solutions that can reactivate tumor-specific immune responses and enhance the body's own immune system in combating cancer. With a commitment to advancing cancer therapies, GenFleet serves both domestic and international markets.

MindRank is an artificial intelligence (AI)-driven drug discovery company focused on streamlining the drug development process. Utilizing its proprietary AI platforms, including PharmKG, Molecule Dance, and Molecule Pro, the company aims to expedite the creation of small molecule medicines that offer unique benefits and improved clinical outcomes. MindRank's technology efficiently recommends cost-effective synthesis routes for various compounds and supports drug design, enabling clients to develop effective pharmaceuticals more quickly and efficiently. Through its innovative approach, MindRank seeks to transform the landscape of drug discovery.

Beijing Sudo Technology specializes in privacy protection services through comprehensive engineering solutions. The company has developed an encryption platform that enables secure data collaboration by utilizing advanced technologies such as cryptography, federated learning, and robust data engineering. This platform facilitates multi-party data collaboration while ensuring that original data remains untransmitted, allowing clients to work together securely and privately.

Datong Insurance is a professional third-party financial insurance service organization. Datong’s subsidiaries include Datong Insurance Sales Service Co., Ltd., Beijing Datong Insurance Brokers Co., Ltd., among which Datong Insurance Sales Service Co., Ltd. is approved by the China Insurance Regulatory Commission. The first national insurance professional sales and service organization approved to be established. At present, the Datong service network has covered more than 20 provinces and municipalities across the country.

NeuraMatrix is a developer of advanced brain-computer interface technology that focuses on enhancing human-computer interaction through a comprehensive hardware-software platform. The company aims to facilitate research in brain science and neurological diseases, offering innovative solutions for diagnosis, treatment, and drug development. NeuraMatrix recently secured substantial funding to support its initiatives, which will be allocated toward upgrading research and development equipment, mass production of chips, product iterations, and market promotion. By leveraging its technology, NeuraMatrix seeks to unlock significant commercial applications in the field of neuroscience and improve the integration of users with technological systems.

H.Extract is a company focused on the research, development, promotion, and sales of pharmaceutical ERP solutions. As a leading brand in China's pharmaceutical distribution sector, H.Extract has implemented its Cloud ERP System in over 40,000 pharmacies nationwide. The company formed a strategic partnership with Tencent Cloud and WeChat Pay in 2016 to enhance the efficiency of the medicine distribution industry, particularly in pharmaceutical wholesale and chain drugstores. With 14 years of experience, H.Extract leverages its technical expertise and management skills to cater to a diverse client base, including major players in the pharmaceutical sector such as Harbin Pharmaceutical Group and Hainan Zhangzhongjing Dispensary. The company's commitment to innovation and high-quality service aims to streamline operations within the pharmaceutical supply chain.

Meike Solar is engaged in the manufacturing of solar photovoltaic polycrystalline silicon wafers. The company emphasizes research and development to enhance its product offerings and utilizes integrated monitoring systems and equipment to support intelligent manufacturing processes. This approach enables Meike Solar to produce its products efficiently while minimizing costs.

JOINN Biologics is a California Bay Area-based company specializing in contract development and manufacturing services for biologics and advanced therapies. With over 20 years of experience, the company supports drug discovery and development through a comprehensive range of services, including molecular assessment, cGMP clinical trial materials production, commercial-scale manufacturing, and various process developments. JOINN Biologics also provides analytical and formulation development, along with documentation support for regulatory filings. The company aims to accelerate the development of high-quality biologics, thereby addressing patient needs and delivering lasting value to the biotech and biopharmaceutical sectors. By owning full intellectual property for cell line engineering, JOINN Biologics helps mitigate intellectual property issues faced by research and development organizations.

PAQ Therapeutics is a biotechnology company focused on restoring health and curing diseases by harnessing autophagy, the body's natural process for cellular degradation. The company develops a novel class of small-molecule degraders using autophagosome-tethering compound technology. This innovative approach allows these compounds to bind a diverse array of substrates to the autophagy pathway, enabling healthcare providers to create effective treatments for serious diseases where traditional therapeutic options are often limited. Through its research and development efforts, PAQ Therapeutics aims to provide new solutions for patients in need of advanced medical therapies.

Xianghuanji is a marketing company that operates an online platform dedicated to cell phone rental services. The platform enables clients to rent cell phones through a subscription model, streamlining the process of obtaining mobile devices on a rental basis. By utilizing a single platform for these services, Xianghuanji simplifies the experience for users seeking flexible access to cell phones without the commitment of purchase.

Chengdu Qitan Technology Co., Ltd. specializes in the development and manufacture of advanced gene sequencing instruments utilizing nanopore technology. Founded in 2016 and based in Chengdu, China, the company offers a fourth generation gene sequencer that enables single-molecule sequencing with long read lengths and real-time output. This innovative technology is designed to serve various sectors, including biopharmaceuticals, healthcare, and agriculture, facilitating applications such as immunophenotyping, pathogen detection, analysis of intestinal flora, and tumor genome detection. Qitan Tech's solutions are notable for their cost-effectiveness and simplicity, as they do not require complicated library preparation, thus enhancing the accessibility of gene sequencing for cutting-edge biological research and clinical diagnostics.

Duality Biologics, founded in January 2020 by Dr. John Zhu, is a biotechnology company focused on developing innovative therapies for oncology and autoimmune diseases. The company is dedicated to addressing unmet medical needs through its internal pipeline, which includes nearly ten promising bispecific antibodies and Antibody-Drug Conjugate (ADC) candidates, several of which are in the investigational new drug (IND) stage. Duality Bio has established a next-generation ADC platform, backed by global intellectual property rights, to enhance drug development. The efficacy of this platform is demonstrated by multiple drug candidates currently under development, aimed at improving treatment outcomes for patients suffering from cancer and autoimmune disorders.

Zhongke Jiuyuan focuses on the manufacturing and sales of key materials such as polyimide films and slurries.

Reliable Med is a developer and provider of clinical mass spectrometry equipment designed for in vitro diagnostic (IVD) tests. The company focuses on addressing the needs of the medical industry by offering high-end clinical mass spectrometry devices and IVD detection kits. By doing so, Reliable Med aims to enhance the efficiency and accuracy of patient diagnoses within the healthcare sector.

EdiGene Inc. is a biotechnology company based in Beijing, China, with additional offices in Guangzhou and Cambridge, Massachusetts. Founded in 2015, EdiGene specializes in the development of advanced genome editing technologies aimed at addressing various genetic diseases and cancer. The company focuses on both ex vivo and in vivo gene-editing therapies, utilizing proprietary platforms for modifying genetic information in human cells. Their innovative approaches include gene knockout, knock-in, and targeted mutations, which facilitate the creation of safer and more effective gene therapies. EdiGene also supports pharmaceutical research by providing high-throughput genome screening and drug target analysis, enhancing drug discovery efforts in the industry. Through its commitment to translating genome editing into therapeutics, EdiGene aims to improve human health outcomes and advance scientific research.

Synaptic Medical Inc. is a medical device company that develops and commercializes products aimed at treating cardiac arrhythmias and other cardiovascular diseases. Founded in 2005, the company operates from its headquarters in St. Paul, Minnesota, and has an additional office in Beijing, China. Synaptic Medical specializes in cardiac electrophysiology products, including bipolar pacing systems, fixed curve and deflectable diagnostic catheters, pulmonary vein mapping catheters, and ablation technologies. The company's mission is to create innovative, cost-effective, and clinically advanced solutions that enhance treatment options for physicians and their patients.

Shanghai ANE Logistics Co., Ltd., founded in 2010 and based in Hangzhou, China, specializes in trucking and logistics services, focusing on less than truckload (LTL) operations. The company has pioneered a franchise model within China's LTL industry, establishing a comprehensive national delivery network that includes approximately 5,000 franchised stores. To support its logistics operations, Shanghai ANE Logistics operates 50 distribution centers and utilizes self-operated sorting centers, along with contracted line-haul trucks for efficient transportation. This innovative approach enables the company to effectively manage logistics and distribution across the country.

Innolake Biopharm is a clinical-stage biotechnology company specializing in the development of therapeutic drugs aimed at treating oncology and autoimmune diseases. The company is actively engaged in research and development, focusing on innovative solutions to address tumors and immune system disorders. With an extensive product development pipeline, Innolake Biopharm seeks to improve patient health outcomes by delivering advanced treatment options.

Gene+ operates in the biotechnology industry, focusing on genetic research and development. The company offers a range of services including gene panel development and mutation detection in peripheral blood. Gene+ also provides Next Generation Sequencing (NGS) services, contributing to the field of oncology. Their Smart Laboratory, known as Gene+sLab, is another key aspect of their operations. The company is also involved in tumor gene detection, offering precision medicine series, tumor whole process monitoring, and early tumor screening and diagnosis services.

GensKey is a medical diagnostic service provider specializing in genetic testing for pathogen diagnosis. Utilizing high-throughput sequencing technology and intelligent algorithm analysis, GensKey addresses traditional challenges such as low detection rates, lengthy processes, and diagnostic accuracy. This innovative approach allows for timely and precise diagnoses for patients suffering from severe infections, ultimately improving patient outcomes by facilitating quicker access to appropriate medical interventions.

EdiGene Inc. is a biotechnology company based in Beijing, China, with additional offices in Guangzhou and Cambridge, Massachusetts. Founded in 2015, EdiGene specializes in the development of advanced genome editing technologies aimed at addressing various genetic diseases and cancer. The company focuses on both ex vivo and in vivo gene-editing therapies, utilizing proprietary platforms for modifying genetic information in human cells. Their innovative approaches include gene knockout, knock-in, and targeted mutations, which facilitate the creation of safer and more effective gene therapies. EdiGene also supports pharmaceutical research by providing high-throughput genome screening and drug target analysis, enhancing drug discovery efforts in the industry. Through its commitment to translating genome editing into therapeutics, EdiGene aims to improve human health outcomes and advance scientific research.

Kafang is a leading provider of electronic trading solutions in the Chinese capital market, specializing in quantitative trading and transaction systems for financial services and hedge funds. The company focuses on developing advanced algorithmic models that facilitate automated and complex dark pool trading, catering to the needs of institutional clients such as pension funds, investment banks, mutual funds, and hedge funds. By leveraging advanced quantitative methodologies and emerging technologies, Kafang delivers efficient and reliable transaction solutions, enhancing trading execution for its clients in a competitive financial landscape.

Singlomics is a biotechnology company that specializes in single-cell sequencing technology to facilitate antibody drug development aimed at treating infectious diseases and cancers. The company has made significant advancements in antibody discovery, having developed neutralizing antibodies such as DXP593 and DXP604, which offer potential solutions in the fight against COVID-19. By leveraging its innovative technology, Singlomics focuses on creating targeted therapies that address critical health challenges.

MicuRx Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering and developing antibiotics to address drug-resistant bacterial infections. Founded in 2007 and headquartered in Palo Alto, California, the company has established a hybrid business model that leverages U.S. research and development alongside cost-effective scientific resources in China. MicuRx's product lineup includes MRX-I, an oral antibiotic targeting multi-drug resistant gram-positive pathogens, and its intravenous prodrug form, MRX-IV. Additionally, the company offers MRX-V, an injectable antibiotic for gram-negative bacteria, and MRX-VIII, a polymyxin for gram-negative infections. The company is also working on a pipeline of antibacterial drugs aimed at combating both gram-positive and gram-negative bacterial pathogens. MicuRx's subsidiary, Shanghai MicuRx, is responsible for commercializing its agents in China while global clinical studies continue.

AccuMedical is a full-line product company in the field of neurological intervention, headquartered in Beijing with an R&D center located in California. It develops and produces medical device products for the treatment of aneurysms, preventing, and treating bleeding diseases caused by the rupture of vascular aneurysms.

Shukun Technology is a Chinese healthcare company founded in 2017 and headquartered in Beijing. It specializes in developing diagnostic systems that leverage machine learning and artificial intelligence to detect cardiovascular diseases and tumors. By employing deep learning algorithms, Shukun Technology intelligently analyzes medical images to automatically identify lesions and generate comprehensive reports. The company's innovations aim to enhance the efficiency of medical professionals, ultimately improving the quality of diagnosis and treatment in primary healthcare settings.

Immvira, founded in Shenzhen, China, in May 2015 by a group of prominent professors from various universities, is focused on developing biopharmaceutical technology in the field of immunotherapy. The company specializes in creating oncolytic viruses and vector-type approaches aimed at treating cancer. Its primary product is a genetically engineered Oncolytic Herpes Simplex Virus, which is designed to target metastatic tumors or tumors that are difficult to access by direct injection. By leveraging this innovative technology, Immvira aims to provide more effective treatment solutions for patients suffering from cancer.

Galaxis technology group, founded in 2014, is a high-tech enterprise focusing on providing integrated logistics automation and robotics solutions and one-stop service. It brings together first-class technical experts and teams from home and abroad. With years of experience in logistics and technical accumulation, has more than hundreds of software copyright, and the national patent, formed the consulting including logistics system planning, software development, system integration, operation guidance, and multi-layer shuttle, high speed lift, AGV, sorting system such as the core research and development of high-end equipment manufacturing as a whole solution, the construction of logistics system can provide customers with one-stop service. High standards, refined product and service quality have kept the company in a leading position in the industry.The application cases are widely applied in more than 10 industries, such as medicine, e-commerce, clothing, books, rail,transit, automobile, etc., and more than 150 large and medium-sized modern logistics centers and production three-dimensional warehouses have been constructed, with the total investment of the project exceeding 20 billion rmb. Headquartered in Jiaxing, the group has technology r&d centers in Germany and Austria, subsidiaries or factories in eight cities of Shanghai, Beijing, Guangzhou, Wuhan, Jiaxing, Wuxi, Chengdu and Kunming. Their vision is to become the world's leading supplier of logistics robots and high-end equipment, technical service providers and system integrators. Focus on customers, continuous innovation, let the world do not hard logistics!

Quantinfo Technology is a financial information and technology company based in Shanghai, China, founded in 2014. The company specializes in providing quantitative trading solutions for financial institutions, focusing on electronic trading services that include market data cleansing, trading strategy development, execution, and risk management. Its flagship products, FinOne Backtesting and FinOne Quant Trading, offer tools for developing quantitative trading strategies, managing historical market data, and conducting backtesting. The firm serves various markets, including income, Forex, and precious metals, and counts major banks and financial institutions among its clients, such as ICBC and CITIC Securities. Through its comprehensive offerings, Quantinfo Technology enables clients to enhance their trading capabilities and achieve better market outcomes.

Tcpjw offers invoicing supply chain platforms in China. Using big data, cloud and fintech innovation, Tcpjw creates a transparent online trading platform for enterprises to manage efficiency.

Alebund Pharmaceuticals is a biopharmaceutical company focused on developing innovative therapies for renal diseases and related chronic conditions. The company specializes in the research, development, regulatory approval, and commercialization of medicines aimed at treating various kidney diseases, including chronic kidney disease, complications associated with dialysis, nephropathy, diabetic kidney disease, and autosomal dominant polycystic kidney disease. With a diversified and balanced pipeline of drug candidates, Alebund Pharmaceuticals aims to provide comprehensive and high-quality solutions for patients suffering from renal diseases.

Chifang Information Technology specializes in intelligent investment and trading platforms.

Kafang is a leading provider of electronic trading solutions in the Chinese capital market, specializing in quantitative trading and transaction systems for financial services and hedge funds. The company focuses on developing advanced algorithmic models that facilitate automated and complex dark pool trading, catering to the needs of institutional clients such as pension funds, investment banks, mutual funds, and hedge funds. By leveraging advanced quantitative methodologies and emerging technologies, Kafang delivers efficient and reliable transaction solutions, enhancing trading execution for its clients in a competitive financial landscape.

JOINN Biologics is a California Bay Area-based company specializing in contract development and manufacturing services for biologics and advanced therapies. With over 20 years of experience, the company supports drug discovery and development through a comprehensive range of services, including molecular assessment, cGMP clinical trial materials production, commercial-scale manufacturing, and various process developments. JOINN Biologics also provides analytical and formulation development, along with documentation support for regulatory filings. The company aims to accelerate the development of high-quality biologics, thereby addressing patient needs and delivering lasting value to the biotech and biopharmaceutical sectors. By owning full intellectual property for cell line engineering, JOINN Biologics helps mitigate intellectual property issues faced by research and development organizations.

Yijiaoyoupei is a teacher learning platform, dedicated to helping the teacher group complete professional training, so that each teacher can easily improve their professional level; there are many training topics in the platform. The workshop is equipped with various learning resources. Users only need to select the corresponding topics according to their needs to start the training.

Genome Wisdom is a precision medical technology service provider specializing in gene-based solutions for clinical and personal genomes. The company focuses on delivering high-throughput, high-precision genomic data services, including the analysis of disease molecular mechanisms through multi-omics integration and the dynamics of oncology treatments. Utilizing artificial intelligence and big data technologies, Genome Wisdom aids clients in biomarker discovery based on genetic and pathological data, thereby enhancing clinical efficiency. Additionally, the firm engages in the design and implementation of scientific research projects, particularly in areas such as molecular pathology analysis and tumor surveillance.

iSoftStone is China's leading smart city technology service and operator. Focus on the use of emerging technologies such as big data, cloud computing, Internet of Things, artificial intelligence, etc., based on urban development needs, precipitating urban data, providing integrated design, construction and operation services for digital and intelligent cities in China.

Founded in September 2011, Life Real focuses on developing and producing life sciences and clinical diagnostic products. The company has developed a range of fully automated integrated molecular diagnostic equipment designed to meet the scientific research needs of the life sciences sector. Life Real is committed to providing cost-effective clinical diagnostic solutions and is currently undertaking necessary product certification processes. Its offerings include a variety of laboratory equipment such as autoclavable pipettes, pipette controllers, micro UV spectrophotometers, and geneReady homogenizers. These products are designed to enhance the safety and convenience of laboratory experiments and testing. Life Real's products are compliant with RoHS standards and CE certified, with options for OEM and ODM cooperation available to meet specific customer requirements.

Zuodashi specializes in the research and development, production, and sales of food and compound seasonings. The company focuses on creating a diverse range of condiments designed to enhance the flavor of takeaway food. In addition to its condiment offerings, Zuodashi has developed software that assists restaurants in managing takeaway applications through a unified platform. This combination of product and technology aims to improve the overall experience for both food providers and consumers.

OnVideo provides a cloud-based video creation platform that enables users to produce professional-quality videos online. The platform offers a range of video editing software in three tiers: free, basic, and premium, catering to different user preferences and needs. This allows individuals to customize their video projects effectively, regardless of their skill level. By leveraging this technology, OnVideo empowers users to create their own movies with a professional touch, making video production accessible to a wider audience.

MGI Tech is a company focused on providing effective and affordable healthcare solutions through the development of advanced life science tools. The company produces clinical high-throughput gene sequencers, along with essential equipment, consumables, and reagents that support life science research and healthcare. MGI Tech's multi-omics platforms encompass genetic sequencing, mass spectrometry, medical imaging, and laboratory automation. By offering real-time, comprehensive systems designed for precision medicine and healthcare, MGI Tech aims to enhance healthcare delivery and drive innovation in digital health.

GeneQuantum Healthcare (Suzhou) Co., Ltd. is a high-tech company specializing in the research and development of innovative biotherapeutics, particularly in the field of anti-tumor therapies. Founded in August 2013 in Suzhou Industrial Park, the company has established a world-class bio-conjugation technology platform that utilizes a ligase-dependent conjugation method. This advanced technology significantly enhances the therapeutic window for developing a series of next-generation Antibody-Drug-Conjugates (ADCs). GeneQuantum is actively working on advancing its ADC candidates towards Investigational New Drug (IND) applications in both the United States and China, while also focusing on expanding its product pipeline to address unmet medical needs in cancer treatment.

Hunan Kexin Health Industry Development Co., Ltd. is a specialized oncology hospital group based in Changsha, China, established in 2014. The company operates a chain of cancer hospitals that offer a comprehensive range of services, including tumor screening, diagnosis, treatment, and rehabilitation. Kexin Health is dedicated to integrating modern medical technology with traditional Chinese medicine, thereby enhancing its clinical offerings. In addition to patient care, the organization is involved in scientific research and technology development, aiming to advance the field of oncology through professional diagnoses and innovative treatment methods.

Xiaoyu Link is an online video conference solution provider. Xiaoyu Link plans to use the proceeds to enhance its sales and marketing efforts, as well as carrying out research in new products and technologies.

Zhiteng Education is focused on the development and training of primary school students aged 4 to 12, specifically targeting their extracurricular potential. The organization has dedicated years to researching and innovating educational programs that enhance children's cognitive skills, memory, and creativity. By providing specialized training courses and developing advanced teaching models and aids, Zhiteng Education aims to improve developmental outcomes for children. Additionally, the company offers educational support to parents, fostering an environment that promotes holistic growth and learning for young students. Through its unique approach and commitment to excellence, Zhiteng Education seeks to make a significant impact on children's educational journeys.

Shukun Technology is a Chinese healthcare company founded in 2017 and headquartered in Beijing. It specializes in developing diagnostic systems that leverage machine learning and artificial intelligence to detect cardiovascular diseases and tumors. By employing deep learning algorithms, Shukun Technology intelligently analyzes medical images to automatically identify lesions and generate comprehensive reports. The company's innovations aim to enhance the efficiency of medical professionals, ultimately improving the quality of diagnosis and treatment in primary healthcare settings.

Haihe Biopharma is dedicated to the discovery, development, and commercialization of innovative anti-tumor drugs aimed at addressing complex diseases. The company specializes in pharmacological efficacy evaluation and offers a range of products, including novel topoisomerase I inhibitors and highly selective oral c-Met inhibitors. By focusing on these advancements, Haihe Biopharma seeks to enhance health outcomes for patients and improve the quality of research in the pharmaceutical field.

Aidong Super AI is an industrial Internet services company that leverages artificial intelligence to enhance equipment management and industrial security. Its offerings include a range of products and solutions aimed at improving operational efficiency and safety. The company focuses on digitizing and optimizing fleet operations, particularly in managing forklifts, which allows for increased transparency and management effectiveness. Among its key products are systems designed to improve vehicle efficiency, AI-driven sanitation monitoring, and technology for identifying runners' gait. By addressing operational challenges related to personnel and asset efficiency, Aidong Super AI positions itself as a valuable partner for businesses seeking to enhance their industrial operations.

EdiGene Inc. is a biotechnology company based in Beijing, China, with additional offices in Guangzhou and Cambridge, Massachusetts. Founded in 2015, EdiGene specializes in the development of advanced genome editing technologies aimed at addressing various genetic diseases and cancer. The company focuses on both ex vivo and in vivo gene-editing therapies, utilizing proprietary platforms for modifying genetic information in human cells. Their innovative approaches include gene knockout, knock-in, and targeted mutations, which facilitate the creation of safer and more effective gene therapies. EdiGene also supports pharmaceutical research by providing high-throughput genome screening and drug target analysis, enhancing drug discovery efforts in the industry. Through its commitment to translating genome editing into therapeutics, EdiGene aims to improve human health outcomes and advance scientific research.

Ruizhi Hechuang Technology is a big data integration service provider. Ruizhi Hechuang Technology designs big data analysis and application technology, carries out key technological breakthroughs in industries, formulates important technical standards, and gathers and trains technological talents urgently needed by the industry. The company provides significant value, high intelligence, and the latest digital solutions to help financial institutions digitally change.

Songxiaocai is a mobile Internet platform that facilitates the trading of agricultural products through an online B2B marketplace. It provides a range of services, including vegetable picking, distribution, and after-sales support, specifically tailored for small and medium-sized retailers. By offering comprehensive solutions that encompass information retrieval, purchasing, and efficient distribution, Songxiaocai enables farmers, wholesalers, and retailers to conduct their business operations more effectively.

Shukun Technology is a Chinese healthcare company founded in 2017 and headquartered in Beijing. It specializes in developing diagnostic systems that leverage machine learning and artificial intelligence to detect cardiovascular diseases and tumors. By employing deep learning algorithms, Shukun Technology intelligently analyzes medical images to automatically identify lesions and generate comprehensive reports. The company's innovations aim to enhance the efficiency of medical professionals, ultimately improving the quality of diagnosis and treatment in primary healthcare settings.

Karaku is a Gaming Platform.

Kalaku is an indoor entertainment, new retail and marketing interaction services company.

Xianlepin is a purchase retail platform.

Bairong is an independent technology platform based in China that offers professional financial information services primarily to large companies in the financial services industry. Utilizing artificial intelligence, cloud computing, and blockchain technology, Bairong focuses on exploring innovative applications that enhance the digital transformation of financial institutions. The company aims to empower these institutions to innovate while also promoting financial inclusion. Through its AI-driven solutions, Bairong supports financial organizations in navigating the evolving landscape of technology in finance.

13 Month Culture is a music production and related services company that specializes in various aspects of the music industry. The company offers services including music production, music creation, and artist management. Additionally, it is involved in the operation of music festivals, focusing on the incubation and cultivation of new music artists. By coordinating music events and providing comprehensive support to artists, 13 Month Culture plays a significant role in the development and promotion of emerging talent within the music landscape.

Rebecca is committed to the application of precision-controlled MEMS radio frequency technology in clinical disease control and rehabilitation. Its core technology comes from the core team's many years of experience and achievements in research and development and productization at the University of California, Fortune 500 medical equipment, and electronic equipment companies. The company cooperated with domestic university research institutes and many top three hospitals in Beijing, Shanghai, and Hangzhou to independently develop micro-radio frequency technology that surpassed similar products in Europe and America. It focuses on delivering innovative medical solutions to the hands of professional caregivers. Rebecca's team possesses technical expertise in micro-devices, RF, and device integration through years of field practice in micro-electronics and clinical innovation.

IPao is an internet car rescue platform. They provide small road assistance businesses and provide services such as towing, tire changes, battery charging, and more, enabling users to call for road assistance.

Louxiaoyi offers courier distribution services that incorporate office buildings. They solve the problem of sending and receiving express delivery in office buildings through a combination of online and offline methods. They use the WeChat light application to realize the user's express delivery notification, self-service, and various value-added services.

Nine strong biological is an in-vitro diagnostic reagent and biochemical detection instrument developer, specializing in the development and production of in vitro diagnostic products, its products include small, dense low-density lipoprotein cholesterol, fibronectin, retinol binding protein.

Yiwai publishes articles and videos introducing art to the public.

Cool College is a SaaS enterprise intelligent & digital management learning platform for corporate and employee training services.

Beijing Rogrand Electronic Commerce Co., Ltd. is a private company established in 2012, specializing in medical e-commerce integrated services in China. The firm operates as a comprehensive service platform that encompasses the entire pharmaceutical industry chain, facilitating connections among pharmaceutical companies, pharmacies, clinics, and medical institutions. Rogrand aims to innovate within the pharmaceutical sector by providing a circulation platform that enhances the efficiency and effectiveness of medical commerce, ultimately contributing to the overall advancement of healthcare services in the region.

SWS Hemodialysis Care Co., Ltd. has been a leader in blood purification since its founding in 2001. The company operates in four main areas: manufacturing blood purification equipment, producing consumables, providing an Advanced Hemodialysis Management System, and managing a network of dialysis centers. SWS focuses on delivering comprehensive medical solutions for patients with chronic kidney disease, showcasing its commitment to patient welfare through safe and effective products and services. The organization emphasizes innovation, holding nearly 200 patents and recognized as a national demonstration enterprise for technological advancement. SWS has established national and industry standards, contributing significantly to the field. Its high-quality products, which are CE marked and certified under ISO 13485:2016, have been installed in numerous medical facilities worldwide, benefiting patients in over 80 countries. SWS's dedication to enhancing patient wellness is reflected in its ongoing commitment to advanced integrated blood purification technologies and its partnerships with top-tier hospitals and medical institutions.

No Panda Culture (Bukongwenhua) is a Shanghai-based entertainment and culture agency.

Suzhou Lonwin Medical Systems is a manufacturer specializing in medical imaging equipment aimed at enhancing the affordability and effectiveness of medical diagnostics and treatment. The company produces a range of products, including magnetic resonance imaging (MRI) systems, computerized tomography (CT) systems, and direct digital x-ray imaging systems. Lonwin's offerings span four key areas: magnetic resonance imaging, radiography, imaging-related products, and interventional therapy-related products. By providing advanced medical imaging solutions, Lonwin enables healthcare practitioners and hospitals to deliver high-quality, efficient, and cost-effective imaging services to their patients.

SinoVision is a medical device manufacturing company based in China, established in 2012. It specializes in the development of computed tomography (CT) scanners, offering a range of products including 16-Slice, 32-Slice, and 64-Slice CT scanners. The company also provides advanced technologies such as the sROBOT robot CT navigation system and sAI intelligent imaging solutions. SinoVision holds intellectual property for CT detectors and designs X-ray tubes and high-voltage power supplies specifically for CT scanners. Additionally, it operates a cloud diagnosis platform that integrates CT image post-processing workstations with an online consultation platform, facilitating comprehensive imaging diagnoses for healthcare professionals and institutions.